Abstract 4139: Investigations of drug synergy reveal promising efficacy of EphA2 inhibition combined with CDK inhibition in triple-negative breast cancer - KIVIRID

Abstract 4139: Investigations of drug synergy reveal promising efficacy of EphA2 inhibition combined with CDK inhibition in triple-negative breast cancer

Authors: Kalin L. Wilson, Dana M. Brantley-Sieders

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-4139

Source: Full article

Abstract

Abstract